Klotho concentrations in the serum, urine, and dialysate were measured by an ELISA system (Immuno-Biological Laboratories, Gunma, Japan) [11]. The presence of Klotho in peritoneal dialysate samples was also evaluated by immuno-blotting (IB) analysis as described previously, with several modifications [12]. Briefly, we added 4× NuPAGE® sample buffer (Invitrogen NP0007, Carlsbad, CA, USA) containing 400 mM dithiothreitol (DTT) check details to the samples. Then the samples

were heated at 100°C for 5 min and then cooled on ice. The protein was separated by sodium dodecyl sulfate (SDS)-4–12% polyacrylamide gel electrophoresis, and transferred onto a nitrocellulose membrane using the iBlot®Dry Blotting System (Invitrogen). The membrane was incubated in SEA BLOCK blocking buffer (Thermo Scientific, Rockford, IL, USA) for 1 h at room temperature and subjected to IB analysis with

anti-Klotho primary antibody KM2076, 3.5 mg/ml, 1:5000 dilution, overnight at 4°C. Subsequently, the membrane was washed and incubated in ECL™ anti-rat IgG (GE Healthcare, Piscataway, NJ, USA) followed by detection using SuperSignal® West Femto Maximum sensitivity substrate (Thermo Scientific) according to the manufacturer’s instructions. All clearance measurements were performed on the same serum and urine or dialysate samples. The formula: Clearance (ml/min) = [U (mg/dl) × Vo (l/day)]/P (mg/dl), was used to evaluate the daily renal clearance rates of creatinine (Ccr) and urea (Cun). U is the urinary concentration, Selisistat Vo is the 24-h urine volume, and P is the serum concentration Tau-protein kinase just after the 24-h urine and dialysate collection period. The same equation was used to calculate the peritoneal clearance rates for creatinine and urea, using the dialysate volume and concentration instead of those of urine. The data were expressed

either as numbers of participants or as a percentage (%) of the study population. The remaining data were expressed as means ± SD, medians, and interquartile ranges (IRs) for variables of a skewed distribution. The relationship between soluble Klotho and residual renal function or peritoneal clearance was evaluated with Pearson’s product moment correlation. p values of less than 0.05 were considered to be statistically significant. Statistical analyses were performed using the SigmaPlot software program 11 for Windows (Systat Software, San Jose, CA, USA). Results The clinical and demographic profiles of the click here patients who were undergoing PD treatment are summarized in Table 1. Twenty-seven (75%) patients were treated with continuous ambulatory peritoneal dialysis (CAPD) and the other nine patients (25%) were treated with automated peritoneal dialysis (APD). The most common underlying cause of renal failure was chronic glomerulonephritis, in twenty-four patients (67%), and diabetic nephropathy was thought to be the cause of renal failure in seven patients (19%).